Biggest News Aggregation in the World
📰 Cientific News

Page 60 - Cientific News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Cientific. Real-time updates on events, politics, business and more.

Head to Head Review: Technip Energies (OTCMKTS:THNPY) vs. ENGlobal (NASDAQ:ENG)

Technip Energies (OTCMKTS:THNPY – Get Rating) and ENGlobal (NASDAQ:ENG – Get Rating) are both professional, scientific, and technical services companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, profitability, analyst recommendations, valuation, earnings and risk. Institutional and Insider Ownership 8.4% of ENGlobal […]
United States Williama Coskey Englobal Corp Technip Energies Get Rating Technip Energies Daily

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Reliable On-Site Gas Generators for Laboratory Applications

Peak Scientific is the world leader in the manufacture and support of laboratory grade gas generators, providing highly reliable and robust solutions, validated by the world's leading instrument manufacturers for many laboratory applications, including, LC-MS (Liquid Chromatography – Mass Spectrometry) and GC (Gas Chromatography). Click to read more...
Peak Scientific Liquid Chromatography Mass Spectrometry Gas Chromatography

MyndBlue Announces the Publication in Scientific Reports of the Discovery of a Predictive Biosignature in Major Depressive Disorder, Derived From Physiological Measurements of Outpatients Using Machine Learning

MyndBlue, a digital MedTech company specializing in major depressive disorder (MDD), post-traumatic stress disorder (PTSD), and artificial intelligence, announces the publication in the prestigious journal
United States Nicolas Ricka Pierre Alexis Geoffroy Denis Fompeyrine Ai Research At Myndblue Chronos Center

Biogen Inc.: FDA Grants Accelerated Approval for QALSODY (tofersen) for SOD1-ALS, a Major Scientific Advancement as the First Treatment to Target a Genetic Cause of ALS

FDA granted accelerated approval of QALSODY based on a reduction of neurofilament, a marker of neurodegeneration1Superoxide dismutase 1 (SOD1)-amyotrophic lateral sclerosis (ALS) is a devastating, uniformly
Puerto Rico United Kingdom United States Timothym Miller Jean Swidler Tudur Smith

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science